Article
Trends and variation in andexanet alfa for the reversal of direct oral anticoagulants in NHS Trusts in England
2025-01-22
Abstract excerpt
Andexanet alfa was recommended by the National Institute for Health and Clinical Excellence (NICE) as an option in the management of major gastrointestinal bleeding in patients taking apixaban or rivaroxaban in May 2021. To assess the uptake of andexanet alfa, we analysed pharmacy stock control data from NHS Trusts in England using the openly available Secondary Care Medicines Dataset. Between May 2021 and July 20...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- c3e0acaa-ab4d-53ca-afa2-8c63df4dc942
- DOI
- 10.1101/2025.01.21.25320733
